CSIMarket
 


180 Life Sciences Corp  (ATNF)
Other Ticker:  
 
 

ATNF's EPS from Cont. Operations Growth by Quarter and Year

180 Life Sciences's EPS from Cont. Operations results by quarter and year




ATNF EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.64 0.03 -0.05
III Quarter September -1.29 -0.55 0.56 -0.64
II Quarter June -0.70 0.09 -0.75 -1.21
I Quarter March 1.27 0.05 -0.58 -0.05
FY   -0.72 -1.05 -0.74 -1.95



ATNF EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment
180 Life Sciences Corp in the third quarter 2023 recorded EPS loss from Cont. Operations of $ -1.29 .

According to the results reported in the third quarter 2023, 180 Life Sciences Corp achieved the best EPS from Cont. Operations growth in Major Pharmaceutical Preparations industry. While 180 Life Sciences Corp' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2023.




ATNF EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 2440 % - - -
FY   - - - -

Financial Statements
180 Life Sciences's third quarter 2023 EPS from Cont. Operations $ -1.29 ATNF's Income Statement
180 Life Sciences's third quarter 2022 EPS from Cont. Operations $ -0.55 Quarterly ATNF's Income Statement
New: More ATNF's historic EPS from Cont. Operations Growth >>


ATNF EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - -94.64 % -
III Quarter September - - - -
II Quarter June - 80 % - -
I Quarter March - 66.67 % - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

180 Life Sciences's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATNF's III. Quarter Q/Q EPS from Cont. Operations Comment
Recent accomplishment of -1.29 by 180 Life Sciences Corp come out even worse considering the EPS loss from Cont. Operations -0.70 in the second quarter.

Within Major Pharmaceutical Preparations industry 180 Life Sciences Corp achieved highest sequential EPS from Cont. Operations growth. While 180 Life Sciences's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATNF's III. Quarter Q/Q EPS from Cont. Operations Comment
III. Quarter 2023 accomplishment of -1.29 by 180 Life Sciences Corp appear even more unfavourable compare to the EPS loss from Cont. Operations -0.70 in the previous quarter.

Within Major Pharmaceutical Preparations industry 180 Life Sciences Corp achieved highest sequential EPS from Cont. Operations growth. While 180 Life Sciences's EPS from Cont. Operations growth quarter on quarter, overall rank is .


180 Life Sciences's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -1.36 $ -0.62 $ 0.17 $ -1.05 $ -0.38
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
180 Life Sciences Corp' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Sep 30 2023 period.
The results are detiriorating as the cumulative EPS loss from Cont. Operations is getting bigger from $ -0.62 for the period from Jun 30 2023 to Sep 30 2022 and $ 0.7311354299876 from the TTM period ending Sep 30 2022 Amanda White wrote.

180 Life Sciences Corp achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
180 Life Sciences Corp' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Sep 30 2023 period.
The results are worsening as the cumulative EPS loss from Cont. Operations is getting bigger from $ -0.62 for the period from Jun 30 2023 to Sep 30 2022 and $ 0.7311354299876 for the twelve months ending in the quarter a year ago.

180 Life Sciences Corp achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
ATNF's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for ATNF's Competitors
EPS from Cont. Operations Growth for 180 Life Sciences's Suppliers
EPS from Cont. Operations Growth for ATNF's Customers

You may also want to know
ATNF's Annual Growth Rates ATNF's Profitability Ratios ATNF's Asset Turnover Ratio ATNF's Dividend Growth
ATNF's Roe ATNF's Valuation Ratios ATNF's Financial Strength Ratios ATNF's Dividend Payout Ratio
ATNF's Roa ATNF's Inventory Turnover Ratio ATNF's Growth Rates ATNF's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2023
Amphastar Pharmaceuticals Inc 215.63%$ 215.625 
Alpha Pro Tech Ltd 200.00%$ 200.000 
Conduit Pharmaceuticals Inc 200.00%$ 200.000 
Boston Scientific Corporation183.33%$ 183.333 
Viemed Healthcare Inc 166.67%$ 166.667 
Davita Inc 132.76%$ 132.759 
Cadre Holdings Inc 123.08%$ 123.077 
Lantheus Holdings Inc 116.85%$ 116.854 
Orasure Technologies Inc114.29%$ 114.286 
Electromed Inc 100.00%$ 100.000 
Molecular Templates inc 86.36%$ 86.364 
Select Medical Holdings Corp80.95%$ 80.952 
Align Technology inc 70.97%$ 70.968 
Integer Holdings Corporation70.83%$ 70.833 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com